相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Smoking and the intestinal microbiome
Ziv Savin et al.
ARCHIVES OF MICROBIOLOGY (2018)
Trimethylamine N-Oxide: A Link among Diet, Gut Microbiota, Gene Regulation of Liver and Intestine Cholesterol Homeostasis and HDL Function
Marina Canyelles et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target
Manuel H. Janeiro et al.
NUTRIENTS (2018)
Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors
Xinmin S. Li et al.
EUROPEAN HEART JOURNAL (2017)
Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta-Analysis of Prospective Studies
Yoriko Heianza et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Gut Microbiota in Cardiovascular Health and Disease
W. H. Wilson Tang et al.
CIRCULATION RESEARCH (2017)
Integrating diet and inflammation to calculate cardiovascular risk
Jessica Gambardella et al.
ATHEROSCLEROSIS (2016)
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
Weifei Zhu et al.
CELL (2016)
Plasma Trimethylamine N-Oxide, a Gut Microbe-Generated Phosphatidylcholine Metabolite, Is Associated With Atherosclerotic Burden
Vichai Senthong et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Trimethylamine N-Oxide: The Good, the Bad and the Unknown
Manuel T. Velasquez et al.
TOXINS (2016)
Trimethylamine N-Oxide Promotes Vascular Inflammation Through Signaling of Mitogen-Activated Protein Kinase and Nuclear Factor-κB
Marcus M. Seldin et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control
Daniel M. Mueller et al.
ATHEROSCLEROSIS (2015)
Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis
Zeneng Wang et al.
CELL (2015)
Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective
Tomas Jernberg et al.
EUROPEAN HEART JOURNAL (2015)
Role of the Microbiota in Immunity and Inflammation
Yasmine Belkaid et al.
CELL (2014)
Prognostic Value of Elevated Levels of Intestinal Microbe-Generated Metabolite Trimethylamine-N-Oxide in Patients With Heart Failure Refining the Gut Hypothesis
W. H. Wilson Tang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Diet rapidly and reproducibly alters the human gut microbiome
Lawrence A. David et al.
NATURE (2014)
Trimethylamine-N-Oxide, a Metabolite Associated with Atherosclerosis, Exhibits Complex Genetic and Dietary Regulation
Brian J. Bennett et al.
CELL METABOLISM (2013)
Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk
W. H. Wilson Tang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Novel Functional Risk Factors for the Prediction of Cardiovascular Events in Vulnerable Patients Following Acute Coronary Syndrome
Martin K. Reriani et al.
CIRCULATION JOURNAL (2012)
Responses of Gut Microbiota to Diet Composition and Weight Loss in Lean and Obese Mice
Yann Ravussin et al.
OBESITY (2012)
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Zeneng Wang et al.
NATURE (2011)